Horndalsveen H, Haakensen VD, Madebo T, Grønberg BH, Halvorsen TO, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Aanerud M, Ahvonen J, Silvoniemi M, Bjaanæs MM, Farooqi S, Nebdal D, Dalsgaard AM, Danielsen BK, Børve M, Dalen TS, Öjlert ÅK, Helland Å (2025)
Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab
Front Oncol, 15, 1681420
DOI 10.3389/fonc.2025.1681420, PubMed 41199847

Haj Mohammad SF, van der Pol H, Vrdoljak E, Lassen U, Ojamaa K, Jalkanen K, Verlingue L, Stenzinger A, Patócs A, Curigliano G, Baltruškevičienė E, Helland Å, Russnes HG, Ługowska I, Mainoli B, Edsjö A, Lonardi E, Taskén K, Gelderblom H (2025)
A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium
ESMO Open, 10 (11), 105872 (in press)
DOI 10.1016/j.esmoop.2025.105872, PubMed 41197434

Ghimire B, Booth N, Lönnberg T, Aittokallio T (2025)
Nextpie: a web-based reporting tool and database for reproducible nextflow pipelines
Bioinform Adv, 5 (1), vbaf252
DOI 10.1093/bioadv/vbaf252, PubMed 41180966